3D Bioprinting Market Size, Share, Growth, Forecast 2032

3D Bioprinting Market

3D Bioprinting Market by Component (Bioinks and 3D Bioprinters), By Application (Cartilage & Bone, Blood Vessels, Skin, and Others), and End User (Biopharmaceutical Companies, Academic Institutes & Research Organizations, and Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032

Category: Healthcare Report Format : PDF Pages: 218 Report Code: ZMR-4865 Published Date: May-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 1526.58 Million USD 5,527.83 Million 15.37% 2023

3D Bioprinting Market: Industry Prospective

According to the report, global demand for 3D bioprinting market was valued at approximately USD 1526.58illion in 2023, and is expected to generate revenue of around USD 5,527.83illion by end of 2032, growing at a CAGR of around 15.37% between 2024 and 2032.

3D Bioprinting Market SizeRequest Free Sample

The report covers forecast and analysis for the 3D bioprinting market on a global and regional level. The study provides historic data from 2018 along with a forecast from 2023 to 2032 based on revenue (USD Million). The study includes drivers and restraints for the 3D bioprinting market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the 3D bioprinting market on a global as well as regional level.

3D Bioprinting Market: Overview

In order to give the users of this report a comprehensive view on the 3D bioprinting market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product and services segment is benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the 3D bioprinting market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the 3D bioprinting market on global and regional basis.

Global 3D Bioprinting MarketRequest Free Sample

3D Bioprinting Market Growth Dynamics

Bioprinting is a manufacturing process in which biomaterials like growth factors and cells are united to manufacture tissue-like systems that mimic natural tissues. The 3D bioprinting uses bioink to make assemblies in a layer-by-layer method. The 3D bioprinting technology has major applications in the field of bioengineering and medicine. There are three major steps in bioprinting namely, pre-bioprinting, bioprinting, and post-bioprinting.

Factors such as increasing use of 3D bioprinting in cosmetic surgical procedures, major innovations in the field of 3D bioprinting, growing cases of kidney and heart failure, restricted number of organ donors, rapidly growing aging population, and increasing demand for organ transplantation will act as major driving factors in the growth of global 3D bioprinting market. Increasing funding for bioprinting and technological advancements in 3D printing will act as an opportunity for the market players in the 3D bioprinting market. Nonetheless, stern regulations regarding 3D printing of biomaterials, dearth of skilled professionals, high cost of 3D printing equipment, and limitations of 3D printed biomaterials will restrict the growth of global 3D bioprinting market.

3D Bioprinting Market Report Scope

Report Attributes Report Details
Report Name 3D Bioprinting Market
Market Size in 2023 USD 1.53 Billion
Market Forecast in 2032 USD 5.53 Billion
Growth Rate CAGR of 15.37%
Number of Pages 218
Key Companies Covered EnvisionTEC GmbH, Organovo Holdings Inc., Cyfuse Biomedical K.K., 3Dynamic Systems Ltd, Nano3D Biosciences, Inc., Aspect Biosystems Ltd., and BioBots
Segments Covered By Application, By Component, By End User and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

3D Bioprinting Market Segmentation Analysis

The global 3D bioprinting market has been split into component, application, end user, and region.

Based on component, 3D bioprinting market has been segmented into bioinks and 3D bioprinters. The 3D bioprinters segment accounted for the highest market share in 2023 due to approval and launch of new and innovative products, growing research and development activities, and support from government agencies. The bioinks segment has been divided into synthetic bioinks, natural bioinks, and hybrid bioinks. The 3D bioprinters segment has been divided into laser-assisted bioprinting, magnetic 3d bioprinting, microextrusion bioprinter, inkjet 3d bioprinting, and other bioprinters.

The application segment has been segmented into clinical applications and research applications. The research applications segment is expected to grow at highest CAGR within the projected time frame. The clinical applications segment has been divided into cartilage & bone, blood vessels, skin, and others. The research applications segment has been divided into 3D cell culture, regenerative medicine, and drug research.

The end user segment has been segmented into biopharmaceutical companies, academic institutes & research organizations, and hospitals. The academic institutes & research organizations accounted for the highest market share in 2023 due to increasing user of 3D bioprinting in academic institutes & research organizations worldwide.

3D Bioprinting Market: Competitive Space

The report also includes detailed profiles of key players such as

  • EnvisionTEC GmbH
  • Organovo Holdings Inc.
  • Cyfuse Biomedical K.K.
  • 3Dynamic Systems Ltd
  • Nano3D Biosciences, Inc.
  • Aspect Biosystems Ltd.
  • and BioBots among others.

3D Bioprinting Market: Regional Insights

North America will be the leading region during the forecast period. Rapid uptake of 3D bioprinting technologies, support from government agencies, and availability of latest healthcare setup will boost the market growth in this region. Europe will be the second largest market. The major reasons are presence of skilled researchers, rise in awareness regarding use of 3D printing, and inadequate number of organ donors.

Global 3D Bioprinting Market SizeRequest Free Sample

Asia Pacific will propagate at speedy rate over the forecast period due to growing activity in bioprinting research, increasing demand for organ transplantation, investment by key market players in the region, and growing research in stem cell and regenerative medicine. Latin America market will develop at a significant rate during the forecast period. The Africa and Middle Eastern countries are likely to experience perceptible growth in the estimated time-frame.

This report segments the Global 3D Bioprinting Market as follows:

Global 3D Bioprinting Market: By Component

  • Bioinks
    • Synthetic Bioinks
    • Natural Bioinks
    • Hybrid Bioinks
  • 3D Bioprinters
    • Laser-assisted Bioprinting
    • Magnetic 3d Bioprinting
    • Microextrusion Bioprinter
    • Inkjet 3d Bioprinting
    • Other Bioprinters

Global 3D Bioprinting Market: By Application

  • Clinical Applications
    • Cartilage & Bone
    • Blood Vessels
    • Skin
    • Others
  • Research Applications

Global 3D Bioprinting Market: By End User

  • Biopharmaceutical Companies
  • Academic Institutes & Research Organizations
  • Hospitals

Global 3D Bioprinting Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

 

Table Of Content

Methodology

FrequentlyAsked Questions

3D bioprinting is an advanced manufacturing technique that involves using specialized 3D printers to create three-dimensional structures composed of living cells, biomaterials, and other biological components. This technology enables the precise deposition of bioinks (materials containing living cells) layer by layer, allowing the creation of complex tissue and organ-like structures.

As of my last knowledge update in September 2021, the 3D bioprinting market was a rapidly evolving field with several key factors influencing its growth. While I cannot provide real-time information beyond that date, I can certainly highlight some of the key factors that were expected to influence the growth of the 3D bioprinting market up until that point. It's important to note that the situation may have evolved since then.

According to the report, global demand for 3D bioprinting market was valued at approximately USD 1526.58 million in 2023, and is expected to generate revenue of around USD 5,527.83 million by end of 2032.

growing at a CAGR of around 15.37% between 2024 and 2032. 

North America will be the leading region during the forecast period. Rapid uptake of 3D bioprinting technologies, support from government agencies, and availability of latest healthcare setup will boost the market growth in this region. Europe will be the second largest market. The major reasons are presence of skilled researchers, rise in awareness regarding use of 3D printing, and inadequate number of organ donors. Asia Pacific will propagate at speedy rate over the forecast period due to growing activity in bioprinting research, increasing demand for organ transplantation, investment by key market players in the region, and growing research in stem cell and regenerative medicine. Latin America market will develop at a significant rate during the forecast period. The Africa and Middle Eastern countries are likely to experience perceptible growth in the estimated time-frame.

The report also includes detailed profiles of key players such as EnvisionTEC GmbH, Organovo Holdings Inc., Cyfuse Biomedical K.K., 3Dynamic Systems Ltd, Nano3D Biosciences, Inc., Aspect Biosystems Ltd., and BioBots among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed